Insight

Kelley Wood: OOP costs barrier to US cancer survivors’ access to medical equipment, exacerbating decline

Kelley Wood/LinkedIn

Mar 12, 2025, 11:08

Kelley Wood: OOP costs barrier to US cancer survivors’ access to medical equipment, exacerbating decline

Kelley Wood, Director of Research at ReVital Cancer Rehabilitation, shared a post on LinkedIn:

“JAMA study shows medical equipment out of pocket (OOP) costs are higher than prescription drugs, outpatient services, physical and occupational therapy, emergency department, and hospitalizations.

Despite high levels of mobility disability and high willingness to pay, OOP costs are a barrier for US cancer survivors to access medical equipment, potentially exacerbating long-term functional decline.”

“Use and Spending on Medical Equipment Among US Cancer Survivors”

Authors: Faraz Jafri, Vishal Patel, Syed Qasim Hussaini, Naveen Premnath, Helen Parsons, Anne Blaes, Arjun Gupta.

Kelley Wood

More posts featuring Kelley Wood.

Anne Blaes Arjun Gupta cancer Faraz Jafri Helen Parsons Kelley Wood Medical Equipment Naveen Premnath OncoDaily Oncology OOP costs out-of-pocket costs Syed Qasim Hussaini Vishal Patel

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer